(Q38007753)

26 August 2017

Study designs for the nonclinical safety testing of new vaccine products (English)

1 reference

26 August 2017

Roy Forster

1

1 reference

26 August 2017

24 April 2012

1 reference

Journal of Pharmacological and Toxicological Methods

26 August 2017

1 reference

26 August 2017

66

1 reference

26 August 2017

1

1 reference

26 August 2017

1-7

1 reference

Developmental and reproductive toxicity testing of vaccines.

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Preclinical safety assessment of a DNA vaccine using particle-mediated epidermal delivery in domestic pig, minipig and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

First-in-human clinical trials with vaccines--what regulators want

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Nonhuman primate models to evaluate vaccine safety and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Diversifying animal models: the use of hispid cotton rats (Sigmodon hispidus) in infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

HLA class I transgenic mice: development, utilisation and improvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Overview of global regulatory toxicology requirements for vaccines and adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Repeated administration of whole-cell and acellular pertussis vaccines affects haemodynamics and autonomic responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

A comparative analysis of acute-phase proteins as inflammatory biomarkers in preclinical toxicology studies: implications for preclinical to clinical translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

Nonclinical safety assessment of vaccines and adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

New mouse model for dengue virus vaccine testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.04.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VASCN.2012.04.003

1 reference

26 August 2017

1 reference

PubMed ID

22561062